Summary
65 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 26 USD is left as net profit.
- Revenue grew by 24% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- It pays out more in dividends than it earns: 192% of profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Asset Management)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.3 USD for 1 USD of yearly profit. Over the last five years it was 10.5 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.9% a year over 5 years. Over the last 3 years it grew by 24% a year. For the next fiscal year analysts expect revenue to grow by 7.6%. Earnings per share grew by 9.5% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 25 USD
- Sales and administration 34 USD
- Taxes and other 15 USD
- Net profit 26 USD
Net profit, industry median (Asset Management) 29 USD
Out of every 100 USD of revenue, 26 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 10.48%
- Paid out of profit
- 192%
- Raised in a row
- 1 year
You receive $1.76 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 12
- Hold 5
- Sell 0
Today's price within the analysts' price targets
The average target of $20 is 17% above today's price. 71% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.